Outsourcing

Podcasts

In this episode of the Drug Solutions Podcast, John Koleng, VP of product development and manufacturing for TFF Pharmaceuticals shares outsourcing strategies in biopharma.

Drug Solutions Podcast: Outsourcing vs. Insourcing in Biopharma: Determining the Best Strategy

Editor of Pharmaceutical Technology Europe

Articles

The inaugural Connect in Pharma event will take place on 14 and 15 September in Geneva, Switzerland.

Connecting the Dots for Pharma

Feliza Mirasol is the science editor for 

In this episode of the Drug Solutions Podcast, Feliza Mirasol, Pharmaceutical Technology’s science editor, discusses technologies enabling biologics and emerging therapies manufacturing and development with Barry Holtz, PhD, chief scientific officer of Phylloceuticals, and Professor Yaakov Nahmias, founder and chief scientific officer, Tissue Dynamics and founder and president, Future Meat Technologies.



Drug Solutions Podcast: Biologic Drug Development and Manufacturing

Partnering with an experienced service provider can help companies unlock the commercial potential of new therapeutic approaches.

Unlocking Formulation Expertise

In this episode of the Drug Solutions Podcast, Meg Rivers, senior editor, interviews Joy Aho, senior product manager at Be The Match BioTherapies, about sourcing autologous and allogeneic cell therapies.

Drug Solutions Podcast: Sourcing Autologous and Allogeneic Cell Therapies

Experience is an invaluable asset for outsourcing partners, particularly as more challenging method development services are in demand.

Method Development in Demand

A key benefit for companies when outsourcing formulation development is the broad experience they can gain from a dedicated service provider, particularly for niche markets.

Gaining Formulation Expertise through Partnerships

Industry experts share their top outsourcing tips from both the perspective of companies offering outsourcing services as well as for companies looking to outsource.

What Outsourcing Partners Wish You Knew

Shifting demands from industry innovators is leading to an increased need for flexible and agile outsourcing partners offering broad and integrated models.

Evolving Demands of Process Development Services

James Park is executive vice-president and managing director of the Global Sales Center at Samsung Biologics.

CDMOs need to consistently demonstrate agility as demand increases for newly developed therapeutic modalities.

Contract Development Services